Ozempic is a medication for the management of type 2 diabetes mellitus with the added benefit of weight loss!

Excess Body Fat

Erin Storm, PA-C

Ozempic

At this point, we’ve all heard about the injectable weight loss craze, but these medications were initially intended for the medical management of type 2 diabetes by healthcare providers. Glucagon-like peptide-1 inhibitors are injectable medications administered into subcutaneous (fat) tissue to alter blood glucose, change insulin secretion, slow gastric emptying, and increase satiety for weight management and also blood sugar control. In clinical trials these prescription drugs have also shown reduced body mass index when compared to placebo.
Ozempic (by Novo Nordisk) is food and drug administration approved to treat patients with type 2 diabetes. Ozempic, which is the brand name for the GLP-1 receptor agonist semaglutide, is also marketed as Wegovy for weight management in those with BMI measurements in the overweight or obesity category.

Fat Reduction

Body

Ozempic 1

- Simple blood tests to check blood sugar and kidney function.

Before Treatement

Ozempic 2

- Ozempic is injected into subcutaneous skin once a week.

During Treatment

Ozempic 3

- Patients should expect mild discomfort at the injection site that resolves quickly.

Immediately After Treatment

Ozempic 4

- The first 24 to 48 hours after an injection may cause more significant nausea, vomiting, and diarrhea in some patients.

1 to 2 Days After Treatment

Ozempic 5

- Blood glucose control will evolve over time
- There are not yet clear controlled trials on long term use of these medications 
- Some patients who have stopped taking Ozempic injections have shown weight gain above and beyond what was lost during treatment

Result Notes

Glucagon-like peptide-1 inhibitors are injectable medications administered into subcutaneous (fat) tissue to alter blood glucose, change insulin secretion, slow gastric emptying, and increase satiety for weight management and also blood sugar control

Glucagon-like peptide-1 inhibitors are injectable medications administered into subcutaneous (fat) tissue to alter blood glucose, change insulin secretion, slow gastric emptying, and increase satiety for weight management and also blood sugar control.

AEDIT

AEDIT

Ozempic

Concerns Treated

Excess Body Fat

Concerns Treated

Excess Body Fat

Discover science-backed solutions from AEDIT Medshop

AI Plastic Surgeon™

Scan. Simulate. Share.

Text to download The AI Plastic Surgeon by AEDIT

Ozempic

Concerns Treated

Excess Body Fat

Concerns Treated

Excess Body Fat

Discover science-backed solutions from AEDIT Medshop

Related Procedures

AI Plastic Surgeon™

Scan. Simulate. Share.

Text to download The AI Plastic Surgeon by AEDIT